Drug intelligence / Profile preview

gallium ga 68 gozetotide

Development stage
Approved
Lead developer
Isotopia Molecular Imaging
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

**Gallium ga 68 gozetotide** is a gallium-68-labelled PSMA-11 radiopharmaceutical prepared using the Isoprotrace cold-kit system for positron-emission tomography imaging of prostate-specific membrane antigen-positive lesions in prostate cancer. The urea-based PSMA-targeting peptidomimetic binds glutamate carboxypeptidase 2 on prostate cancer cells, while gallium-68 provides the PET signal. Isoprotrace is supplied as a ready-to-use, multi-dose radiolabelling kit that produces an intravenous diagnostic solution and is indicated for primary staging of high-risk prostate cancer and evaluation of suspected biochemical recurrence. ([isotopia-global.com](https://isotopia-global.com/isoprotrace/))

Brand names
Isoprotrace
Other names
68Ga-isoPROtrace-1168Ga-PSMA-11[68Ga]Ga-PSMA-11gallium Ga 68 gozetotideisoPROtrace-11isoPROtrace11isoPROtrace 11
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on gallium ga 68 gozetotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium ga 68 gozetotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call